BAX and ovarian cancer: Additionally, exogenously expressing HVEM in primary ovarian cancer cells and OVCAR-3 cells markedly reduced the expression of Bax (pro-apoptotic protein) and significantly increased the expression of Bcl-2 (anti-apoptotic protein).